ADMA Biologics, Inc.
ADMANASDAQHealthcareBiotechnology
As of Oct 16, 2026 close
- Market cap
- $2.47B
- P/E (TTM)
- 14.63
- Forward P/E
- 18.82
- Dividend yield
- -
- 52-week range
- $7.21$20.46
- Volume (live)
- -
- Avg. volume (3M)
- 3.14M
ADMA Biologics (ADMA) Stock Price & Financial Analysis
ADMA Biologics Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $10.61 - $10.87 |
|---|---|
| 52-Week High | $20.46 |
| 52-Week Low | $7.21 |
| Open | $10.73 |
| Volume (last close) | 3.07M |
| Average Volume (3M) | 3.14M |
| Revenue (TTM) | 512.27M |
|---|---|
| Net Income (TTM) | 168.96M |
| Free Cash Flow (TTM) | 116.47M |
| EPS (TTM) | $0.70 |
| Profit Margin | 32.98% |
| Operating Margin | 42.26% |
| Return on Equity (ROE) | 41.39% |
| Debt to Equity | 0.48 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
| Market Cap | 2.47B |
|---|---|
| Shares Outstanding | 230.34M |
| P/E Ratio (TTM) | 14.63 |
| Forward P/E | 18.82 |
| Price to Sales (P/S) | 4.82 |
| Price to Book (P/B) | 6.05 |
| EV/EBITDA | 10.92 |
| 50-Day MA | $9.66 |
|---|---|
| 200-Day MA | $11.39 |
| 1-Year Change | −25.28% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
ADMA Biologics at a Glance
As of the Oct 16, 2026 close, ADMA Biologics (ADMA) has a market capitalization of $2.47B. The stock trades at 14.6× trailing earnings, 18.8× forward earnings and 4.8× sales. Over the trailing twelve months it earned $168.96M on revenue of $512.27M (a 33.0% profit margin) and generated $116.47M of free cash flow. Revenue grew 8.0% year over year.
As of its latest reported balance sheet, it holds $136.02M in cash and securities against $196.59M of debt, a net debt position of $60.57M.
ADMA Biologics does not currently pay a dividend.
The share price is down 25.3% over the past year. At $10.68 (the Oct 16, 2026 close) it sits within its 52-week range of $7.21 to $20.46, below its 200-day moving average of $11.39.
Based on 2 professional analyst ratings from the past 90 days, the consensus is Hold.
Frequently Asked Questions About ADMA Biologics
What is the current stock price for ADMA?
As of the Oct 16, 2026 close, ADMA stock trades at $10.68. The 52-week range is $7.21–$20.46, with a day range of $10.61–$10.87.
What is the P/E ratio for ADMA?
As of the Oct 16, 2026 close, ADMA Biologics's trailing twelve-month (TTM) P/E ratio is 14.6, meaning investors pay $14.6 for every $1 of annual earnings. The forward P/E is 18.8, reflecting analyst expectations for future earnings. ADMA Biologics operates in the Healthcare sector.
Does ADMA pay dividends?
ADMA Biologics does not currently pay a regular dividend. The company retains its earnings to reinvest in the business. Check the Dividends tab for historical dividend information.
What do analysts recommend for ADMA?
Based on ratings from 2 professional analysts over the last 90 days, the consensus for ADMA is Hold.
What is the market cap of ADMA?
As of the Oct 16, 2026 close, ADMA Biologics's market capitalization is $2.46B, classifying it as a mid-cap company. ADMA Biologics operates in the Healthcare sector within the Biotechnology industry.